Status:
COMPLETED
Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors
Lead Sponsor:
Radboud University Medical Center
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Tumor cell proliferation and repopulation contribute to resistance to radiotherapy in head and neck cancer. Up to now, this characteristic is mostly assessed using biopsies acquired during inspection ...
Eligibility Criteria
Inclusion
- Stage II - IV squamous cell carcinoma of the head-and-neck region, treated with radiotherapy or radiochemotherapy with curative intent.
- 18 years or older
- Informed consent
Exclusion
- Patients who have undergone surgery as primary tumor therapy.
- Patients treated with palliative intent.
- Pregnancy
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00163176
Start Date
July 1 2005
End Date
December 1 2010
Last Update
December 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen, Department of Radiotherapy
Nijmegen, Gelderland, Netherlands, 6500 HB